Glutaminyl cyclase is an enzymatic modifier of the CD47-SIRP alpha axis and a target for cancer immunotherapy

Author(s):
Logtenberg, M.E.W.; Jansen, J.H.M.; Raaben, M.; Toebes, M.; Franke, K.; Brandsma, A.M.; Matlung, H.L.; Fauster, A.; Gomez-Eerland, R.; Bakker, N.A.M.; Schot, S. van der; Marijt, K.A.; Verdoes, M.; Haanen, J.B.A.G.; Berg, J.H. van den; Neefjes, J.; Berg, T.K. van den; Brummelkamp, T.R.; Leusen, J.H.W.; Scheeren, F.A.; Schumacher, T.N.
Published
2019
Publication type
Article / Letter to editor
Date issued
2019-04-30
Language
English
Is part of
Nature Medicine (2019), Vol. 25, no. 4, p. 612-+
hdl
1887/119828
doi
10.1038/s41591-019-0356-z